Support WBURRemdesivir Priced At More Than $3,100 For A Course Of TreatmentPlay04:12Download AudioSydney LupkinJune 29, 2020 ShareGilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected. (POOL/AFP via Getty Images)
